Australian Clinical Labs Statistics

Total Valuation

Australian Clinical Labs has a market cap or net worth of AUD 697.49 million. The enterprise value is 979.78 million.

Market Cap	697.49M
Enterprise Value	979.78M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	Sep 4, 2024

Share Statistics

Australian Clinical Labs has 199.28 million shares outstanding. The number of shares has decreased by -0.82% in one year.

Current Share Class	n/a
Shares Outstanding	199.28M
Shares Change (YoY)	-0.82%
Shares Change (QoQ)	-1.85%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	58.32%
Float	173.27M

Valuation Ratios

The trailing PE ratio is 29.17 and the forward PE ratio is 18.12. Australian Clinical Labs's PEG ratio is 1.33.

PE Ratio	29.17
Forward PE	18.12
PS Ratio	1.00
PB Ratio	3.95
P/TBV Ratio	n/a
P/FCF Ratio	4.56
P/OCF Ratio	n/a
PEG Ratio	1.33

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.13, with an EV/FCF ratio of 6.40.

EV / Earnings	40.94
EV / Sales	1.41
EV / EBITDA	5.13
EV / EBIT	15.66
EV / FCF	6.40

Financial Position

The company has a current ratio of 0.64, with a Debt / Equity ratio of 1.74.

Current Ratio	0.64
Quick Ratio	0.52
Debt / Equity	1.74
Debt / EBITDA	1.62
Debt / FCF	2.02
Interest Coverage	3.67

Financial Efficiency

Return on equity (ROE) is 13.84% and return on invested capital (ROIC) is 8.01%.

Return on Equity (ROE)	13.84%
Return on Assets (ROA)	6.67%
Return on Capital (ROIC)	8.01%
Revenue Per Employee	142,116
Profits Per Employee	4,884
Employee Count	4,900
Asset Turnover	1.19
Inventory Turnover	27.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.26% in the last 52 weeks. The beta is 1.18, so Australian Clinical Labs's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	+37.26%
50-Day Moving Average	3.61
200-Day Moving Average	2.85
Relative Strength Index (RSI)	46.40
Average Volume (20 Days)	1,000,634

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Australian Clinical Labs had revenue of AUD 696.37 million and earned 23.93 million in profits. Earnings per share was 0.12.

Revenue	696.37M
Gross Profit	254.00M
Operating Income	62.55M
Pretax Income	36.37M
Net Income	23.93M
EBITDA	76.31M
EBIT	62.55M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

The company has 26.85 million in cash and 308.90 million in debt, giving a net cash position of -282.05 million or -1.42 per share.

Cash & Cash Equivalents	26.85M
Total Debt	308.90M
Net Cash	-282.05M
Net Cash Per Share	-1.42
Equity (Book Value)	177.77M
Book Value Per Share	0.89
Working Capital	-74.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 159.59 million and capital expenditures -6.51 million, giving a free cash flow of 153.09 million.

Operating Cash Flow	159.59M
Capital Expenditures	-6.51M
Free Cash Flow	153.09M
FCF Per Share	0.77

Full Cash Flow Statement

Margins

Gross margin is 36.47%, with operating and profit margins of 8.98% and 3.44%.

Gross Margin	36.47%
Operating Margin	8.98%
Pretax Margin	5.22%
Profit Margin	3.44%
EBITDA Margin	10.96%
EBIT Margin	8.98%
FCF Margin	21.98%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 3.43%.

Dividend Per Share	0.12
Dividend Yield	3.43%
Dividend Growth (YoY)	-14.29%
Years of Dividend Growth	n/a
Payout Ratio	83.35%
Buyback Yield	0.82%
Shareholder Yield	4.25%
Earnings Yield	3.43%
FCF Yield	21.95%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Australian Clinical Labs has an Altman Z-Score of 2.24. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.24
Piotroski F-Score	n/a